192 related articles for article (PubMed ID: 18669627)
1. Inhibition of ADRP prevents diet-induced insulin resistance.
Varela GM; Antwi DA; Dhir R; Yin X; Singhal NS; Graham MJ; Crooke RM; Ahima RS
Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G621-8. PubMed ID: 18669627
[TBL] [Abstract][Full Text] [Related]
2. Reduction of TIP47 improves hepatic steatosis and glucose homeostasis in mice.
Carr RM; Patel RT; Rao V; Dhir R; Graham MJ; Crooke RM; Ahima RS
Am J Physiol Regul Integr Comp Physiol; 2012 Apr; 302(8):R996-1003. PubMed ID: 22378776
[TBL] [Abstract][Full Text] [Related]
3. Second-generation antisense oligonucleotides against β-catenin protect mice against diet-induced hepatic steatosis and hepatic and peripheral insulin resistance.
Popov VB; Jornayvaz FR; Akgul EO; Kanda S; Jurczak MJ; Zhang D; Abudukadier A; Majumdar SK; Guigni B; Petersen KF; Manchem VP; Bhanot S; Shulman GI; Samuel VT
FASEB J; 2016 Mar; 30(3):1207-17. PubMed ID: 26644352
[TBL] [Abstract][Full Text] [Related]
4. Reduction of hepatosteatosis and lipid levels by an adipose differentiation-related protein antisense oligonucleotide.
Imai Y; Varela GM; Jackson MB; Graham MJ; Crooke RM; Ahima RS
Gastroenterology; 2007 May; 132(5):1947-54. PubMed ID: 17484887
[TBL] [Abstract][Full Text] [Related]
5. Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents.
Vatner DF; Goedeke L; Camporez JG; Lyu K; Nasiri AR; Zhang D; Bhanot S; Murray SF; Still CD; Gerhard GS; Shulman GI; Samuel VT
Diabetologia; 2018 Jun; 61(6):1435-1446. PubMed ID: 29497783
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting monoacylglycerol acyltransferase 1 ameliorates hepatic metabolic abnormalities but not inflammation and injury in mice.
Soufi N; Hall AM; Chen Z; Yoshino J; Collier SL; Mathews JC; Brunt EM; Albert CJ; Graham MJ; Ford DA; Finck BN
J Biol Chem; 2014 Oct; 289(43):30177-88. PubMed ID: 25213859
[TBL] [Abstract][Full Text] [Related]
7. Reduced adiposity and improved insulin sensitivity in obese mice with antisense suppression of 4E-BP2 expression.
Yu XX; Pandey SK; Booten SL; Murray SF; Monia BP; Bhanot S
Am J Physiol Endocrinol Metab; 2008 Mar; 294(3):E530-9. PubMed ID: 18198353
[TBL] [Abstract][Full Text] [Related]
8. Effects of perilipin 2 antisense oligonucleotide treatment on hepatic lipid metabolism and gene expression.
Imai Y; Boyle S; Varela GM; Caron E; Yin X; Dhir R; Dhir R; Graham MJ; Ahima RS
Physiol Genomics; 2012 Nov; 44(22):1125-31. PubMed ID: 23012396
[TBL] [Abstract][Full Text] [Related]
9. Metformin prevents hepatic steatosis by regulating the expression of adipose differentiation-related protein.
Liu F; Wang C; Zhang L; Xu Y; Jang L; Gu Y; Cao X; Zhao X; Ye J; Li Q
Int J Mol Med; 2014 Jan; 33(1):51-8. PubMed ID: 24253218
[TBL] [Abstract][Full Text] [Related]
10. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
11. Dissociation of hepatic insulin resistance from susceptibility of nonalcoholic fatty liver disease induced by a high-fat and high-carbohydrate diet in mice.
Asai A; Chou PM; Bu HF; Wang X; Rao MS; Jiang A; DiDonato CJ; Tan XD
Am J Physiol Gastrointest Liver Physiol; 2014 Mar; 306(6):G496-504. PubMed ID: 24436353
[TBL] [Abstract][Full Text] [Related]
12. Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance.
Choi CS; Savage DB; Kulkarni A; Yu XX; Liu ZX; Morino K; Kim S; Distefano A; Samuel VT; Neschen S; Zhang D; Wang A; Zhang XM; Kahn M; Cline GW; Pandey SK; Geisler JG; Bhanot S; Monia BP; Shulman GI
J Biol Chem; 2007 Aug; 282(31):22678-88. PubMed ID: 17526931
[TBL] [Abstract][Full Text] [Related]
13. CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance.
Brown JM; Betters JL; Lord C; Ma Y; Han X; Yang K; Alger HM; Melchior J; Sawyer J; Shah R; Wilson MD; Liu X; Graham MJ; Lee R; Crooke R; Shulman GI; Xue B; Shi H; Yu L
J Lipid Res; 2010 Nov; 51(11):3306-15. PubMed ID: 20802159
[TBL] [Abstract][Full Text] [Related]
14. The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach.
Raichur S; Brunner B; Bielohuby M; Hansen G; Pfenninger A; Wang B; Bruning JC; Larsen PJ; Tennagels N
Mol Metab; 2019 Mar; 21():36-50. PubMed ID: 30655217
[TBL] [Abstract][Full Text] [Related]
15. Reversion of steatosis by SREBP-1c antisense oligonucleotide did not improve hepatic insulin action in diet-induced obesity mice.
Vitto MF; Luz G; Luciano TF; Marques SO; Souza DR; Pinho RA; Lira FS; Cintra DE; De Souza CT
Horm Metab Res; 2012 Nov; 44(12):885-90. PubMed ID: 22932913
[TBL] [Abstract][Full Text] [Related]
16. Role of patatin-like phospholipase domain-containing 3 on lipid-induced hepatic steatosis and insulin resistance in rats.
Kumashiro N; Yoshimura T; Cantley JL; Majumdar SK; Guebre-Egziabher F; Kursawe R; Vatner DF; Fat I; Kahn M; Erion DM; Zhang XM; Zhang D; Manchem VP; Bhanot S; Gerhard GS; Petersen KF; Cline GW; Samuel VT; Shulman GI
Hepatology; 2013 May; 57(5):1763-72. PubMed ID: 23175050
[TBL] [Abstract][Full Text] [Related]
17. PPARalpha activation increases triglyceride mass and adipose differentiation-related protein in hepatocytes.
Edvardsson U; Ljungberg A; Lindén D; William-Olsson L; Peilot-Sjögren H; Ahnmark A; Oscarsson J
J Lipid Res; 2006 Feb; 47(2):329-40. PubMed ID: 16282640
[TBL] [Abstract][Full Text] [Related]
18. Up-regulation of ADRP in fatty liver in human and liver steatosis in mice fed with high fat diet.
Motomura W; Inoue M; Ohtake T; Takahashi N; Nagamine M; Tanno S; Kohgo Y; Okumura T
Biochem Biophys Res Commun; 2006 Feb; 340(4):1111-8. PubMed ID: 16403437
[TBL] [Abstract][Full Text] [Related]
19. CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistance.
Cantley JL; Yoshimura T; Camporez JP; Zhang D; Jornayvaz FR; Kumashiro N; Guebre-Egziabher F; Jurczak MJ; Kahn M; Guigni BA; Serr J; Hankin J; Murphy RC; Cline GW; Bhanot S; Manchem VP; Brown JM; Samuel VT; Shulman GI
Proc Natl Acad Sci U S A; 2013 Jan; 110(5):1869-74. PubMed ID: 23302688
[TBL] [Abstract][Full Text] [Related]
20. Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2.
Savage DB; Choi CS; Samuel VT; Liu ZX; Zhang D; Wang A; Zhang XM; Cline GW; Yu XX; Geisler JG; Bhanot S; Monia BP; Shulman GI
J Clin Invest; 2006 Mar; 116(3):817-24. PubMed ID: 16485039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
